Christina Ackermann, a director at Verona Pharma plc ($VRNA), sold shares on the open market twice in the last year for a total of $361 thousand. Her most recent sale occurred on August 1, 2025. These transactions rank 7,165th among 11,678 insiders by sale value, well below the average of 8.6 million across 6 transactions per seller. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | D | Ordinary Shares | 64072 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | D | Share Options (Right to Buy) | 144000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.02% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | D | Share Options (Right to Buy) | 200000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | M | Ordinary Shares | 24000 | $0.00 | 65,880.0000 | 727,223,000 | 57.31% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | S | Ordinary Shares | 1808 | $13.14 | 64,072.0000 | 727,223,000 | 2.74% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| May 14, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | M | Share Options (Right to Buy) | 40000 | $0.00 | 200,000.0000 | 652,311,000 | 16.67% | 0.01% |
| May 14, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | S | Ordinary Shares | 40000 | $8.44 | 41,880.0000 | 652,311,000 | 48.85% | 0.01% |
| May 14, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | M | Ordinary Shares | 40000 | $1.93 | 81,880.0000 | 652,311,000 | 95.51% | 0.01% |
| April 25, 2025 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| Nov. 6, 2024 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | P | Ordinary Shares | 41880 | $4.74 | 41,880.0000 | 648,217,000 | 9999.99% | 0.01% |
| April 29, 2024 | Verona Pharma plc | $VRNA | ACKERMANN CHRISTINA | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |